Skip to main content

Advertisement

SpringerLink
Log in

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours

  • Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumours (2022) comes out only five years after the previous edition, however it presents important updates that run in parallel with the rapid progression involving the increasingly sophisticated molecular investigation and its interpretation, some of which already have therapy-related impact. This manuscript provides an overview of the leading changes introduced in the classification of Odontogenic and Maxillofacial Bone Tumours that encompasses cysts of the jaws, odontogenic tumours, giant cell lesions and bone cysts, and bone and cartilage tumours. This is the first edition that Essential and Desirable Diagnostic Features were added for each entity, so that the most important clinical, microscopic and/or radiologic features were encapsulated and briefly highlighted. Surgical ciliated cyst was added to the group of odontogenic cysts, adenoid ameloblastoma was a newly recognized benign epithelial odontogenic tumour, and segmental odontomaxillary dysplasia was introduced in the group of fibro-osseous tumours and dysplasia. In addition, rhabdomyosarcoma with TFCP2 rearrangement, was introduced into the group of malignant jawbone tumours. The unique genetic aberrations distinguish it from other types of rhabdomyosarcomas. On the other hand, melanotic neuroectodermal tumour of infancy and osteoid osteoma were deleted from the benign bone and cartilageneous tumours, as was the hematolymphoid tumour of solitary plasmacytoma of bone. We systematically reviewed each entity in this chapter and provided important updated findings for selected topics that can further aid in the diagnostic process for challenging cases, broaden insights on the logic of the present classification, and finally, emphasize the potential that some of the molecular results may have in the near future to set new treatment approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

(data transparency) – N/A.

Code Availability

(software application or custom code) – N/A.

References

  1. WHO Classification of Tumours Editorial Board. Head and neck tumours. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 9). https://publications.iarc.fr/

  2. El-Naggar AK, John KC, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: IARC; 2017

  3. Barnes L, Eveson JW, Reichart P, Sidransky D. WHO Classification of Head and Neck Tumours. 3rd ed. Lyon: IARC; 2005

  4. Bourgeois SL Jr, Nelson BL. Surgical ciliated cyst of the mandible secondary to simultaneous Le Fort I osteotomy and genioplasty: report of case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:36–9.

    PubMed  Google Scholar 

  5. Kahn A, Matalon S, Bassam Salem R, Kats L, Chaushu L, Vered M, Rosen E. Sinus floor augmentation—associated surgical ciliated cysts: case series and a systematic review of the literature. Appl Sci. 2021;11:1903.

    CAS  Google Scholar 

  6. Ledesma-Montes C, Gorlin RJ, Shear M, Praetorius F, Mosqueda-Taylor A, Altini M, Unni K, de Almeida OP, Carlos-Bregni R, de León ER, Phillips V, Delgado-Azañero W, Meneses-García A. International collaborative study on ghost cell odontogenic tumours: calcifying cystic odontogenic tumour, dentinogenic ghost cell tumour and ghost cell odontogenic carcinoma. J Oral Pathol Med. 2008;37:302–8.

    PubMed  Google Scholar 

  7. Yukimori A, Oikawa Y, Morita KI, Nguyen CT, Harada H, Yamaguchi S, Kayamori K, Yamaguchi A, Ikeda T, Sakamoto K. Genetic basis of calcifying cystic odontogenic tumors. PLoS One. 2017;12:e0180224.

    PubMed  PubMed Central  Google Scholar 

  8. Gondak RO, Mariano FV, de Sousa SF, de Siqueira EC, Díaz KP, Martins LA, Altemani A, Mosqueda-Taylor A, Gomez RS, Gomes CC. CTNNB1 and APC mutations in odontogenic carcinoma with dentinoid. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:e249-56.

    PubMed  Google Scholar 

  9. Greer RO, Eskendri J, Freedman P, Ahmadian M, Murakami-Walter A, Varella-Garcia M. Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases. J Oral Pathol Med. 2018;47:192–7.

    CAS  PubMed  Google Scholar 

  10. Stojanov IJ, Schaefer IM, Menon RS, Wasman J, Gokozan HN, Garcia EP, Baur DA, Woo SBG, Sholl LM. Biallelic PTCH1 inactivation is a dominant genomic change in sporadic keratocystic odontogenic tumors. Am J Surg Pathol. 2020;44:553–60.

    PubMed  PubMed Central  Google Scholar 

  11. Jain KS, Bodhankar K, Desai RS, Bansal S, Shirsat P, Prasad P, Shah A. Absence of BRAFV600E immunohistochemical expression in sporadic odontogenic keratocyst, syndromic odontogenic keratocyst and orthokeratinized odontogenic cyst. J Oral Pathol Med. 2020;49:1061–7.

    CAS  PubMed  Google Scholar 

  12. Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhai J, Zhang H, Zhang J, Zhang R, Hong Y, Qu J, Chen F, Li T. Effect of the sonic hedgehog inhibitor GDC-0449 on an in vitro isogenic cellular model simulating odontogenic keratocysts. Oral Dis. 2019;25:1600–7.

    PubMed  Google Scholar 

  14. Wang HC, Jiang WP, Sima ZH, Li TJ. Fibroblasts isolated from a keratocystic odontogenic tumor promote osteoclastogenesis in vitro via interaction with epithelial cells. Oral Dis. 2015;21:170–7.

    PubMed  Google Scholar 

  15. Coura BP, Bernardes VF, de Sousa SF, França JA, Pereira NB, Pontes HAR, Batista AC, da Cruz Perez DE, Albuquerque Junior RLC, de Souza LB, Martins MD, Diniz MG, Gomez RS, Gomes CC. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features. Mod Pathol. 2019;32:799–806.

    CAS  PubMed  Google Scholar 

  16. Chaves RRM, Júnior AACP, Gomes CC, de Castro WH, Gomez RS. Multiple adenomatoid odontogenic tumors in a patient with Schimmelpenning syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129:e12-17.

    PubMed  Google Scholar 

  17. Roza ALOC, Sousa EM, Leite AA, Amaral-Silva GK, Morais TML, Wagner VP, Schuch LF, Vasconcelos ACU, de Arruda JAA, Mesquita RA, Fonseca FP, Abrahão AC, Agostini M, de Andrade BAB, da Silveira EJD, Martínez-Flores R, Rondanelli BM, Alberdi-Navarro J, Robinson L, Marin C, Assunção Júnior JNR, Valiati R, Fregnani ER, Santos-Silva AR, Lopes MA, Hunter KD, Khurram SA, Speight PM, Mosqueda-Taylor A, van Heerden WFP, Carlos R, Wright JM, de Almeida OP, Romañach MJ, Vargas PA. Central odontogenic fibroma: an international multicentric study of 62 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131:549–57.

    PubMed  Google Scholar 

  18. González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol. 2020;11:31–42.

    PubMed  PubMed Central  Google Scholar 

  19. Zlotogorski-Hurvitz A, Soluk Tekkeşin M, Passador-Santos F, Martins Montalli VA, Salo T, Mauramo M, Kats L, Buchner A, Vered M. Conceptual changes in ameloblastoma: suggested re-classification of a “veteran” tumor. Oral Dis. 2021. https://doi.org/10.1111/odi.13770.

    Article  PubMed  Google Scholar 

  20. Hirschhorn A, Campino GA, Vered M, Greenberg G, Yacobi R, Yahalom R, Barshack I, Toren A, Amariglio N, Rechavi G. Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration. J Tissue Eng Regen Med. 2021. https://doi.org/10.1002/term.3254.

    Article  PubMed  Google Scholar 

  21. Jayasooriya PR, Abeyasinghe WAMUL, Liyanage RLPR, Uthpali GN, Tilakaratne WM. diagnostic enigma of adenoid ameloblastoma: literature review based evidence to consider it as a new sub type of ameloblastoma. Head Neck Pathol. 2021. https://doi.org/10.1007/s12105-021-01358-w.

    Article  PubMed  Google Scholar 

  22. Loyola AM, Cardoso SV, de Faria PR, Servato JP, Eisenberg AL, Dias FL, Thavaraj S, Gomes CC, Gomez RS. Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:368–77.

    PubMed  Google Scholar 

  23. Reichart P, Sciubba JJ, Philipsen HP. Splitters or lumpers: the 2017 WHO classification of head and neck tumours. J Am Dent Assoc. 2018;149:567–71.

    PubMed  Google Scholar 

  24. Soluk-Tekkeşin M, Wright JM. The world health organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) Edition. Turk Patoloji Derg. 2018;34:1–18.

    Google Scholar 

  25. Soluk-Tekkesin M, Cakarer S, Aksakalli N, Alatli C, Olgac V. New world health organization classification of odontogenic tumours: impact on the prevalence of odontogenic tumours and analysis of 1231 cases from Turkey. Br J Oral Maxillofac Surg. 2020;58:1017–22.

    CAS  PubMed  Google Scholar 

  26. Fujii S, Nagata K, Matsumoto S, Kohashi KI, Kikuchi A, Oda Y, Kiyoshima T, Wada N. Wnt/β-catenin signaling, which is activated in odontomas, reduces sema3A expression to regulate odontogenic epithelial cell proliferation and tooth germ development. Sci Rep. 2019;9:4257.

    PubMed  PubMed Central  Google Scholar 

  27. Coura BP, Bernardes VF, de Sousa SF, Diniz MG, Moreira RG, de Andrade BAB, Romañach MJ, Pontes HAR, Gomez RS, Odell EW, Gomes CC. Targeted next-generation sequencing and allele-specific quantitative pcr of laser capture microdissected samples uncover molecular differences in mixed odontogenic tumors. J Mol Diagn. 2020;22:1393–9.

    CAS  PubMed  Google Scholar 

  28. de Mesquita Netto AC, Gomez RS, Diniz MG, Fonseca-Silva T, Campos K, De Marco L, Carlos R, Gomes CC. Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:359–67.

    PubMed  Google Scholar 

  29. Riminucci M, Collins MT, Corsi A, Boyde A, Murphey MD, Wientroub S, Kuznetsov SA, Cherman N, Robey PG, Bianco P. Gnathodiaphyseal dysplasia: a syndrome of fibro-osseous lesions of jawbones, bone fragility, and long bone bowing. J Bone Miner Res. 2001;16:1710–8.

    CAS  PubMed  Google Scholar 

  30. Brierley DJ, Crane H, Hunter KD. Lumps and bumps of the gingiva: a pathological miscellany. Head Neck Pathol. 2019;13:103–13.

    PubMed  PubMed Central  Google Scholar 

  31. Pereira NB, Bastos VC, de Souza JC, Diniz MG, Vitório JG, Kitten GT, de Oliveira AL, de Avelar GF, Castro WH, Bernardes VF, Dias AAM, Gomez RS, Gomes CC. First insights for targeted therapies in odontogenic myxoma. Clin Oral Investig. 2020;24:2451–8.

    PubMed  Google Scholar 

  32. Alhousami T, Sabharwal A, Gupta S, Aguirre A, Park E, Kramer JM. Fibromyxoma of the jaw: case report and review of the literature. Head Neck Pathol. 2018;12:44–51.

    PubMed  Google Scholar 

  33. Giridhar P, Mallick S, Upadhyay AD, Rath GK. Pattern of care and impact of prognostic factors in the outcome of ameloblastic carcinoma: a systematic review and individual patient data analysis of 199 cases. Eur Arch Otorhinolaryngol. 2017;274:3803–10.

    PubMed  Google Scholar 

  34. Ko YCK, Varma S, Zhu CF, Zhu SX, Vennam S, Poh CF, Jordan RC, Kong C, Pollack JR, West RB. Gene expression profiling of head and neck tumors identifies foxp1 and sox10 expression as useful for distinguishing ameloblastoma from basaloid salivary gland tumors. Am J Surg Pathol. 2020;44:665–72.

    PubMed  PubMed Central  Google Scholar 

  35. Guastaldi FPS, Faquin WC, Gootkind F, Hashemi S, August M, Iafrate AJ, Rivera MN, Kaban LB, Jaquinet A, Troulis MJ. Clear cell odontogenic carcinoma: a rare jaw tumor. a summary of 107 reported cases. Int J Oral Maxillofac Surg. 2019;48:1405–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E, Diniz MG, Castro WH, St-Onge P, Sinnett D, Han H, Rivera B, Mikael LG, De Jay N, Kleinman CL, Valera ET, Bassenden AV, Berghuis AM, Majewski J, Nelson MT, Gomez RS, Jabado N. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw. Nat Commun. 2018;9:4572.

    PubMed  PubMed Central  Google Scholar 

  37. Ragamin A, Gomes CC, Bindels-de Heus K, Sandoval R, Bassenden AV, Dib L, Kok F, Alves J, Mathijssen I, Medici-Van den Herik E, Eveleigh R, Gayden T, Pullens B, Berghuis A, van Slegtenhorst M, Wilke M, Jabado N, Mancini GMS, Gomez RS. De novo TRPV4 Leu619Pro variant causes a new channelopathy characterised by giant cell lesions of the jaws and skull, skeletal abnormalities and polyneuropathy. J Med Genet:jmedgenet. 2020. https://doi.org/10.1136/jmedgenet-2020-107427.

    Article  Google Scholar 

  38. Gomes CC, Diniz MG, Bastos VC, Bernardes VF, Gomez RS. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing. J Pathol. 2020;250:126–33.

    PubMed  Google Scholar 

  39. Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA. SP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Nel C, Yakoob Z, Schouwstra CM, van Heerden WF. Familial florid cemento-osseous dysplasia: a report of three cases and review of the literature Dentomaxillofac Radiol. 2021;50:20190486.

    PubMed  Google Scholar 

  41. Gibson TM, Rafferty K, Ryan E, Ganguly A, Koutlas IG. Segmental ipsilateral odontognathic dysplasia (mandibular involvement in segmental odontomaxillary dysplasia?) and identification of PIK3CA somatic variant in lesional mandibular gingival tissue. Head Neck Pathol. 2021;15:368–73.

    PubMed  Google Scholar 

  42. Chrcanovic BR, Gomez RS. Juvenile ossifying fibroma of the jaws and paranasal sinuses: a systematic review of the cases reported in the literature. Int J Oral Maxillofac Surg. 2020;49:28–37.

    CAS  PubMed  Google Scholar 

  43. Tabareau-Delalande F, Collin C, Gomez-Brouchet A, Bouvier C, Decouvelaere AV, de Muret A, Pagès JC, de Pinieux G. Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions. Mod Pathol. 2015;28:48–56.

    CAS  PubMed  Google Scholar 

  44. Sarode SC, Sarode GS, Waknis P, Patil A, Jashika M. Juvenile psammomatoid ossifying fibroma: a review. Oral Oncol. 2011;47:1110–6.

    PubMed  Google Scholar 

  45. Jones AC, Prihoda TJ, Kacher JE, Odingo NA, Freedman PD. Osteoblastoma of the maxilla and mandible: a report of 24 cases, review of the literature, and discussion of its relationship to osteoid osteoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:639–50.

    PubMed  Google Scholar 

  46. Amary MF, Berisha F, Mozela R, Gibbons R, Guttridge A, O’Donnell P, Baumhoer D, Tirabosco R, Flanagan AM. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma. Histopathology. 2016;69:121–7.

    PubMed  Google Scholar 

  47. Nord KH, Lilljebjörn H, Vezzi F, Nilsson J, Magnusson L, Tayebwa J, de Jong D, Bovée JV, Hogendoorn PC, Szuhai K. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma. Nat Genet. 2014;46:474–7.

    CAS  PubMed  Google Scholar 

  48. Karimi A, Derakhshan S, Moradzadeh Khiavi M, Mosavat F, Mirjalili F. Desmoplastic fibroma of the jaws: a case series and review of literature. Iran J Pathol. 2020;15:134–43.

    PubMed  PubMed Central  Google Scholar 

  49. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. 2017 The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 67: 93–9

  50. Liang L, Zhang T, You Y, He Q, Fan Y, Liao G. An individual patient data meta-analysis on the effect of chemotherapy on survival in patients with craniofacial osteosarcoma. Head Neck. 2019;41:2016–23.

    PubMed  Google Scholar 

  51. Tallegas M, Miquelestorena-Standley É, Labit-Bouvier C, Badoual C, Francois A, Gomez-Brouchet A, Aubert S, Collin C, Tallet A, de Pinieux G. IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract. Hum Pathol. 2019;84:183–91.

    CAS  PubMed  Google Scholar 

  52. Meijer D, de Jong D, Pansuriya TC, van den Akker BE, Picci P, Szuhai K, Bovée JV. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes Cancer. 2012;51:899–909.

    CAS  PubMed  Google Scholar 

  53. Le Loarer F, Cleven AHG, Bouvier C, Castex MP, Romagosa C, Moreau A, Salas S, Bonhomme B, Gomez-Brouchet A, Laurent C, Le Guellec S, Audard V, Giraud A, Ramos-Oliver I, Cleton-Jansen AM, Savci-Heijink DC, Kroon HM, Baud J, Pissaloux D, Pierron G, Sherwood A, Coindre JM, Bovée JVMG, Larousserie F, Tirode F. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Mod Pathol. 2020;33:404–19.

    PubMed  Google Scholar 

  54. Xu B, Suurmeijer AJH, Agaram NP, Zhang L, Antonescu CR. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases. Histopathology. 2021;79:347–57.

    PubMed  Google Scholar 

Download references

Funding

(Information that explains whether and by whom the research was supported) – N/A.

Author information

Authors and Affiliations

  1. Department of Oral Pathology, Oral Medicine and Maxillofacial Imaging, School of Dental Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel

    Marilena Vered

  2. Institute of Pathology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

    Marilena Vered

  3. Department of Diagnostic Sciences, School of Dentistry, Texas A&M University, Dallas, TX, USA

    John M. Wright

Authors
  1. Marilena Vered
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John M. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors contributed to the writing and editing of the manuscript.

Corresponding author

Correspondence to Marilena Vered.

Ethics declarations

Conflict of interest

(Include appropriate disclosures) – Authors have no conflicts of interests to disclose.

Ethical Approval

This manuscript does not contain studies with human or animals.

Consent to Participate

N/A

Consent for Publication

N/A

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vered, M., Wright, J.M. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours. Head and Neck Pathol 16, 63–75 (2022). https://doi.org/10.1007/s12105-021-01404-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-021-01404-7

Keywords

Search

Navigation